Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

K-Bro Linen Inc T.KBL

Alternate Symbol(s):  KBRLF

K-Bro Linen Inc. is an owner and operator of laundry and linen processing facilities in Canada. The Company provides a comprehensive range of general linen and operating room linen processing, management and distribution services to healthcare institutions, hotels, and other commercial accounts. It operates about ten processing facilities and two distribution centers under two distinctive brands, including K-Bro Linen Systems Inc. and Buanderie HMR, in ten Canadian cities: Quebec City, Montreal, Toronto, Regina, Saskatoon, Prince Albert, Edmonton, Calgary, Vancouver and Victoria. Its Canadian division provides laundry and linen services to the healthcare and hospitality sectors through ten operating divisions. The Company’s UK division provides laundry and linen services primarily to the hospitality sector, with other sectors, including healthcare, manufacturing and pharmaceuticals, through five sites which are located in Cupar, Perth, Newcastle, Livingston and Coatbridge.


TSX:KBL - Post by User

Post by retiredcfon Nov 15, 2024 9:13am
64 Views
Post# 36314589

And Stifel

And StifelTD Cowen’s Derek Lessard raised his K-Bro Linen Inc.  target by $2 to $48 with a “buy” rating, while Stifel’s Justin Keywood increased his target to $46 from $45 with a “buy” rating. The average is $47.67.

“Q3 adds to KBL’s growing record of consistent execution since emerging from the pandemic, and reflects the favourable industry fundamentals (high surgical backlog and healthy leisure and business travel demand),” he said. “The shares are trading only at 7.6 times forward consensus EBITDA (versus five-year average of 9.1 times), which we do not think fairly represents the stock’s attractive risk/reward trade-off.”



<< Previous
Bullboard Posts
Next >>